Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Jan 2021 for Prevail Therapeutics Inc., €634.1M.
Filing timeline
BuySaleTyto Acquisition Corp
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Tyto Acquisition Corp: trading record in brief
One trade, one date: on 22 January 2021, Tyto Acquisition Corp disclosed an open-market purchase of €634.1M in Prevail Therapeutics Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tyto Acquisition Corp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 34,284,789 shares@ US$22.50100.0% of flowCommon StockSEC:0000899243-21-002923:0Canonical exit: 22 Apr 2021 (T+90)
1 of 1 declaration
